Project: A non-invasive treatment to protect visual function in early stage diabetic retinopathy patients
| Acronym | PREVIN (Reference Number: 11008) |
| Duration | 01/04/2017 |
| Project Topic | PREVIN combines a novel drug delivery method to treat patients with Diabetic Retinopathy (DR) (i.e. blindness in Diabetes patients) with established drugs. This method will improve localized drug delivery with cyclodextrin nanoparticles to the back of the eye for effective, safe, low-cost, preventive and non-invasive treatment of DR. PREVIN, supported by extensive safety and efficacy studies, will be ready for licensing within one year after the end of the project. |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 6 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Oculis Pharma | Coordinator | Iceland |
| 2 | Experimentica Ltd | Partner | Finland |
| 3 | Nucro-Technics, a Division of the Vimy Ridge Group Ltd. | Partner | Canada |
| 4 | Medical University of Vienna | Partner | Austria |
| 5 | University of Copenhagen, Zealand University Hospital | Partner | Denmark |